EQL Pharma AB publ announced earnings results for the first quarter ended June 30, 2020. For the first quarter, the company announced sales was SEK 99.505 million compared to SEK 14.459 million a year ago. Operating income was SEK 11.575 million compared to SEK 82,000 a year ago. Net income was SEK 11.209 million compared to SEK 15,000 a year ago.